Modeled Impact of Seasonal Malaria Chemoprevention on District-Level Suspected and Confirmed Malaria Cases in Chad Based on Routine Clinical Data (2013–2018)

Sulfadoxine-pyrimethamine plus amodiaquine is delivered to children aged 3–59 months as seasonal malaria chemoprevention (SMC) in areas where transmission is highly seasonal such as Chad and other Sahelian countries. Although clinical trials show a 75% reduction in malaria cases, evidence of SMC’s i...

Descripción completa

Detalles Bibliográficos
Autores principales: Richardson, Sol, Moukenet, Azoukalne, Diar, Mahamat Saleh Issakha, de Cola, Monica Anna, Rassi, Christian, Counihan, Helen, Roca-Feltrer, Arantxa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society of Tropical Medicine and Hygiene 2021
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8641328/
https://www.ncbi.nlm.nih.gov/pubmed/34662864
http://dx.doi.org/10.4269/ajtmh.21-0314

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8641328/
https://www.ncbi.nlm.nih.gov/pubmed/34662864
http://dx.doi.org/10.4269/ajtmh.21-0314

Ejemplares similares